Results 121 to 130 of about 34,537 (182)

Pharmacological evaluation of an ex vivo cervicovaginal HIV prevention model. [PDF]

J Antimicrob Chemother
Collins LB, Le A, Nicol MR.
europepmc   +1 more source

Hyperlipidemia and associated risk factors among people living with HIV on antiretroviral therapy: a retrospective cohort study from Eastern China. [PDF]

Prev Med Rep
Cheng W, Zhang Y, Yang J, Jiang J, Pan X, Chai C, Wang Y.   +6 more
europepmc   +1 more source

Hepatitis B Virus Reactivation During Rituximab Therapy Despite Anti-HBs Positivity: A Case Report. [PDF]

Cureus
Belhocine R, Lagdali N, Kadiri M, Mohamed B, Ajana FZ.   +4 more
europepmc   +1 more source

Antiretroviral resistance in at least second-line HIV-1 treatment virologic failure with common InSTI-based regimens. [PDF]

AIDS
Marcelin AG, Soulie C, Wirden M, Gruber J, Prata Menezes N, Lim T, Barriere G, Descamps D, Charpentier C, Calvez V.   +9 more
europepmc   +1 more source

Immune Remodeling in People Living with HIV/HBV Co-Infection on Long-Term Therapy: Revisiting the Paradigm of Additive Dysfunction [Letter]. [PDF]

Infect Drug Resist
Peppa D, Alrubayyi A, Bhagani S.
europepmc   +1 more source

Effectivity and safety of TAF in CHB patients with concurrent MASLD: a real-world study. [PDF]

BMC Gastroenterol
Zhang H, Zhou Y, Yu J, Wang Q, Wang X, Chen J, Yu J, Qiao B, Liu Z.   +8 more
europepmc   +1 more source

Tenofovir-induced Fanconi syndrome: a case report and literature review. [PDF]

Oxf Med Case Reports
Park J, Lee F, Yeam A, Hamiduzzaman A, Anavim A, Lau WL.   +5 more
europepmc   +1 more source

Subclinical atherosclerosis assessed by cardio-ankle vascular index and carotid intima-media thickness in people living with HIV receiving integrase inhibitor-based tenofovir regimens. [PDF]

BMC Infect Dis
Vatan A, Karabay O, Moralı H, Kara Y, Güçlü E, Öğütlü A, Vatan MB.   +6 more
europepmc   +1 more source

Evolution and forecasting of antiretroviral therapy utilisation in British Columbia: a population-level analysis of provincial drug treatment programme data, 2014-2024. [PDF]

BMJ Open
Lima VD, Mokhtari Jazi A, Montaner JSG.
europepmc   +1 more source

Comparative effectiveness of antiviral therapies in chronic hepatitis B and C management. [PDF]

Bioinformation
Tiwari A, Tagore PK, Kumhar SD, Bardiya A.   +3 more
europepmc   +1 more source